Search Results 1491-1500 of 16179 for Epilepsy (Partial Onset)

  1. Neurology - Clinical trials - Mayo Clinic

    ... onset of symptoms in MSA. Multiscale EEG Dynamics. Rochester, Minn., Scottsdale/Phoenix, Ariz. The purpose if this study to combine state of the art cerebral ...

  2. Clinical Research and Trials Unit - Center for Clinical and Translational Science

    The Clinical Research and Trials Unit (CRTU) offers investigators the support they need to conduct clinical research, including specially trained nurses, ...

  3. Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in NSCLC With Expansion Cohorts in NSCLC, Melanoma, and Colorectal Cancer - Mayo Clinic

    ... duration of the study, or is not in the best interest of the patient to participate, in the opinion of the treating Investigator, including, but not limited to:.

  4. 7 Tesla MRI in ALSP Patients - Mayo Clinic

    ... onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP). Participation eligibility. Participant eligibility includes age, gender, type and ...

  5. Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors, The PNeoVCA Study - Mayo Clinic

    ... partial thromboplastin time (aPTT) =\< 1.5 x ULN unless patient is receiving anticoagulant therapy in which case PT or PTT must be within target range of ...

  6. Center for Individualized Medicine - Clinical Studies

    The Mayo Clinic Center for Individualized Medicine's clinical studies use genomic products and procedures in new and different ways to diagnose and treat ...

  7. A Study to Evaluate Pembrolizumab Combined with Intensive Chemotherapy to Treat Patients with Acute Myeloid Leukemia - Mayo Clinic

    Drugs used in chemotherapy, such as cytarabine, idarubicin, and daunorubicin, work in different ways to stop the growth of cancer cells, either by killing the ...

  8. Neurology - Clinical trials - Mayo Clinic

    Rochester, Minn. The purpose o fthis study. A total of 8,000 patients presenting to CPSs with acute-onset AIS, ICH or aSAH and no history of dementia ...

  9. Mesenchymal Stem Cells Therapy in Patients With Recent Intracerebral Hemorrhage - Mayo Clinic

    Ability to be enrolled within 72 hours of onset of stroke symptoms. ... onset, or if the patient has symptomatic neurological deterioration from ICH ...

  10. Empagliflozin (oral route) - Mayo Clinic

    fast heartbeat; headache; increased hunger; nausea; nightmares; rapid breathing; seizures; shakiness; slurred speech; sweating; unusual tiredness or weakness ...